Spire Healthcare Group plc
SPI.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.28 | 0.15 | -0.57 | 1.08 |
| FCF Yield | 13.55% | 12.72% | 7.93% | 10.11% |
| EV / EBITDA | 8.59 | 9.15 | 10.53 | 11.33 |
| Quality | ||||
| ROIC | 4.43% | 4.92% | 11.11% | 18.71% |
| Gross Margin | 45.24% | 38.31% | 36.75% | 35.63% |
| Cash Conversion Ratio | 9.28 | 7.32 | 18.66 | -17.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.03% | 7.10% | 9.22% | 4.09% |
| Free Cash Flow Growth | 7.01% | 58.65% | -28.13% | 6.52% |
| Safety | ||||
| Net Debt / EBITDA | 4.95 | 5.22 | 5.78 | 5.83 |
| Interest Coverage | 1.40 | 1.36 | 1.14 | 0.93 |
| Efficiency | ||||
| Inventory Turnover | 17.76 | 18.93 | 18.67 | 17.71 |
| Cash Conversion Cycle | 8.54 | 18.24 | 13.02 | 20.77 |